EE

Serial Number 78355965
606

Registration Progress

Application Filed
Jan 22, 2004
Under Examination
Jul 11, 2006
Approved for Publication
Mar 29, 2006
Published for Opposition
Apr 18, 2006
Registered

Trademark Image

EE

Basic Information

Serial Number
78355965
Filing Date
January 22, 2004
Published for Opposition
April 18, 2006
Abandonment Date
August 10, 2009
Drawing Code
5000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Aug 10, 2009
Classes
005

Rights Holder

EPIGENESIS PHARMACEUTICALS LLC

03
Address
2009 Eastpark Boulevard
CRANBURY, NJ 08512

Ownership History

EPIGENESIS Pharmaceuticals, Inc.

Original Applicant
03
Cranbury, NJ

EPIGENESIS PHARMACEUTICALS LLC

New Owner Before Publication #1
03
CRANBURY, NJ

EPIGENESIS PHARMACEUTICALS LLC

Owner at Publication
03
CRANBURY, NJ

Legal Representation

Attorney
ALBERT P. HALLUIN

USPTO Deadlines

All Deadlines Cleared

All 7 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

47 events
Date Code Type Description Documents
Aug 10, 2009 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Aug 10, 2009 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Jan 6, 2009 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 6, 2009 EXT5 S SOU EXTENSION 5 FILED Loading...
Jan 6, 2009 EX5G S SOU EXTENSION 5 GRANTED Loading...
Jul 1, 2008 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 1, 2008 EXT4 S SOU EXTENSION 4 FILED Loading...
Jul 1, 2008 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jan 7, 2008 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 7, 2008 EXT3 S SOU EXTENSION 3 FILED Loading...
Jan 7, 2008 EX3G S SOU EXTENSION 3 GRANTED Loading...
Sep 9, 2007 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jul 3, 2007 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 3, 2007 EXT2 S SOU EXTENSION 2 FILED Loading...
Mar 13, 2007 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jan 5, 2007 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 5, 2007 EXT1 S SOU EXTENSION 1 FILED Loading...
Jul 11, 2006 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 18, 2006 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 29, 2006 NPUB O NOTICE OF PUBLICATION Loading...
Mar 3, 2006 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Feb 24, 2006 ALIE A ASSIGNED TO LIE Loading...
Feb 22, 2006 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 22, 2006 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 14, 2006 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Feb 14, 2006 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 6, 2005 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 6, 2005 GNRT O NON-FINAL ACTION E-MAILED Loading...
Sep 2, 2005 ZZZX Z PREVIOUS ALLOWANCE COUNT WITHDRAWN Loading...
Aug 15, 2005 CWBP Z WITHDRAWN BEFORE PUBLICATION Loading...
Jul 26, 2005 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Jul 22, 2005 ALIE A ASSIGNED TO LIE Loading...
Jul 21, 2005 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 20, 2005 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 11, 2005 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 11, 2005 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 9, 2005 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 9, 2005 GNRT O NON-FINAL ACTION E-MAILED Loading...
Mar 1, 2005 ACEC I AMENDMENT FROM APPLICANT ENTERED Loading...
Jan 31, 2005 MAIL I PAPER RECEIVED Loading...
Jan 31, 2005 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 5, 2004 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Aug 21, 2004 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 12, 2004 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 20, 2004 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
Jul 16, 2004 MAIL I PAPER RECEIVED Loading...
Feb 2, 2004 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Medical diagnostic and therapeutic preparations for clinical use, all for administration via diverse routes of administration including through the respiratory airways, and, medical devices for administering the pharmaceuticals, sold as a kit, namely inhalers; medical preparations namely nucleotides, proteins and organic molecules for medical use, including macromolecules such as anti-sense oligonucleotides and enzymes and small and inorganic molecules for treatment of human and non-human animal respiratory, central nervous system, neoplastic, endocrine, immune and cardiovascular ailments, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, which in some cases are adenosine receptor associated symptoms; pharmaceutical preparations for testing, and preventing and therapeutically treating respiratory, airway and pulmonary diseases and conditions, such as asthma, pulmonary vasconconstriction, inflammation, allergies, impeded respiration, acute respiratory disease syndrome (ARDS), renal damage and failure, ischemia resulting from the administration of certain drugs, including adenosine and other drugs for, for example, treating supra ventricular tachycardia (SVT), adenosine stress tests, infantile respiratory distress syndrome (infantile RDS), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vasconcontriction, emphysema, chronic obstructive pulmonary disease (COPD), as well as cancers including leukemias, lymphomas, carcinomas, and the like, eg colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, etc, as well as metastatic cancers, eg, cancers which metastasized to the lung(s), breast, liver and prostate
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Design Mark
The mark consists of stylized letter "E" connected to another transposed stylized letter "E" in a top to bottom alignment.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005